319 reports of this reaction
1.3% of all DALTEPARIN SODIUM reports
#19 most reported adverse reaction
MULTIPLE ORGAN DYSFUNCTION SYNDROME is the #19 most commonly reported adverse reaction for DALTEPARIN SODIUM, manufactured by Pfizer Laboratories Div Pfizer Inc. There are 319 FDA adverse event reports linking DALTEPARIN SODIUM to MULTIPLE ORGAN DYSFUNCTION SYNDROME. This represents approximately 1.3% of all 23,703 adverse event reports for this drug.
Patients taking DALTEPARIN SODIUM who experience multiple organ dysfunction syndrome should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
MULTIPLE ORGAN DYSFUNCTION SYNDROME is a less commonly reported adverse event for DALTEPARIN SODIUM, but still significant enough to appear in the safety profile.
In addition to multiple organ dysfunction syndrome, the following adverse reactions have been reported for DALTEPARIN SODIUM:
The following drugs have also been linked to multiple organ dysfunction syndrome in FDA adverse event reports:
MULTIPLE ORGAN DYSFUNCTION SYNDROME has been reported as an adverse event in 319 FDA reports for DALTEPARIN SODIUM. This does not prove causation, but indicates an association observed in post-market surveillance data.
MULTIPLE ORGAN DYSFUNCTION SYNDROME accounts for approximately 1.3% of all adverse event reports for DALTEPARIN SODIUM, making it a notable side effect.
If you experience multiple organ dysfunction syndrome while taking DALTEPARIN SODIUM, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.